8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      PD-1 + melanocortin receptor dependent-Treg cells prevent autoimmune disease

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Experimental autoimmune uveoretinitis (EAU) is a mouse model of human autoimmune uveitis marked by ocular autoantigen-specific regulatory immunity in the spleen. The melanocortin 5 receptor (MC5r) and adenosine 2 A receptor (A2Ar) are required for induction of post-EAU regulatory T cells (Tregs) which provide resistance to EAU. We show that blocking the PD-1/PD-L1 pathway prevented suppression of EAU by post-EAU Tregs. A2Ar induction of PD-1 +FoxP3 + Tregs in uveitis patients was similar compared to healthy controls, but was significantly reduced with melanocortin stimulation. Further, lower body mass index correlated with responsiveness to stimulation of this pathway. These observations indicate an importance of the PD-1/PD-L1 pathway to provide resistance to relapsing uveitis and shows a reduced capacity of uveitis patients to induce Tregs when stimulated through melanocortin receptors, but that it is possible to bypass this part of the pathway through direct stimulation of A2Ar.

          Related collections

          Most cited references33

          • Record: found
          • Abstract: found
          • Article: not found

          The three human monocyte subsets: implications for health and disease.

          Human blood monocytes are heterogeneous and conventionally subdivided into two subsets based on CD16 expression. Recently, the official nomenclature subdivides monocytes into three subsets, the additional subset arising from the segregation of the CD16+ monocytes into two based on relative expression of CD14. Recent whole genome analysis reveal that specialized functions and phenotypes can be attributed to these newly defined monocyte subsets. In this review, we discuss these recent results, and also the description and utility of this new segregation in several disease conditions. We also discuss alternative markers for segregating the monocyte subsets, for example using Tie-2 and slan, which do not necessarily follow the official method of segregating monocyte subsets based on relative CD14 and CD16 expressions.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Phenotype, function, and differentiation potential of human monocyte subsets

            Human monocytes have been grouped into classical (CD14++CD16−), non-classical (CD14dimCD16++), and intermediate (CD14++CD16+) subsets. Documentation of normal function and variation in this complement of subtypes, particularly their differentiation potential to dendritic cells (DC) or macrophages, remains incomplete. We therefore phenotyped monocytes from peripheral blood of healthy subjects and performed functional studies on high-speed sorted subsets. Subset frequencies were found to be tightly controlled over time and across individuals. Subsets were distinct in their secretion of TNFα, IL-6, and IL-1β in response to TLR agonists, with classical monocytes being the most producers and non-classical monocytes the least. Monocytes, particularly those of the non-classical subtype, secreted interferon-α (IFN-α) in response to intracellular TLR3 stimulation. After incubation with IL-4 and GM-CSF, classical monocytes acquired monocyte-derived DC (mo-DC) markers and morphology and stimulated allogeneic T cell proliferation in MLR; intermediate and non-classical monocytes did not. After incubation with IL-3 and Flt3 ligand, no subset differentiated to plasmacytoid DC. After incubation with GM-CSF (M1 induction) or macrophage colony-stimulating factor (M-CSF) (M2 induction), all subsets acquired macrophage morphology, secreted macrophage-associated cytokines, and displayed enhanced phagocytosis. From these studies we conclude that classical monocytes are the principal source of mo-DCs, but all subsets can differentiate to macrophages. We also found that monocytes, in particular the non-classical subset, represent an alternate source of type I IFN secretion in response to virus-associated TLR agonists.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The PD-1/PD-Ls pathway and autoimmune diseases.

              The programmed death (PD)-1/PD-1 ligands (PD-Ls) pathway, is a new member of the B7/CD28 family, and consists of the PD-1 receptor and its ligands PD-L1 (B7-H1, CD274) and PD-L2 (B7-DC, CD273). Recently, it is reported that PD-1, PD-L1 and PD-L2 also have soluble forms aside from their membrane bound forms. The soluble forms increase the diversity and complexity of PD-1/PD-Ls pathway in both composition and function. The PD-1/PD-Ls pathway is broadly expressed and exerts a wider range of immunoregulatory roles in T-cell activation and tolerance compared with other B7/CD28 family members. Studies show that the PD-1/PD-Ls pathway regulates the induction and maintenance of peripheral tolerance and protects tissues from autoimmune attack in physiological conditions. In addition, it is also involved in various diseases mediated by T cells, such as autoimmunity, tumor immunity, chronic viral infections, and transplantation immunity. In this review, we will summarize the relevance of the soluble forms and the latest researches on the role of PD-1/PD-Ls pathway in autoimmune diseases.
                Bookmark

                Author and article information

                Contributors
                darren-lee@ouhsc.edu
                Journal
                Sci Rep
                Sci Rep
                Scientific Reports
                Nature Publishing Group UK (London )
                2045-2322
                15 November 2019
                15 November 2019
                2019
                : 9
                : 16941
                Affiliations
                [1 ]ISNI 0000 0001 2179 3618, GRID grid.266902.9, Department of Microbiology and Immunology, , University of Oklahoma Health Sciences Center, ; Oklahoma City, Oklahoma USA
                [2 ]ISNI 0000 0001 2179 3618, GRID grid.266902.9, Department of Ophthalmology/Dean McGee Eye Institute, , University of Oklahoma Health Sciences Center, ; Oklahoma City, Oklahoma USA
                [3 ]GRID grid.419472.d, Massachusetts Eye Research and Surgery Institute, ; Waltham, Massachusetts USA
                [4 ]GRID grid.490929.f, Ocular Immunology and Uveitis Foundation, ; Waltham, Massachusetts USA
                [5 ]ISNI 000000041936754X, GRID grid.38142.3c, Harvard Medical School, ; Boston, Massachusetts USA
                [6 ]ISNI 0000 0001 2179 3618, GRID grid.266902.9, College of Public Health, , University of Oklahoma Health Sciences Center, ; Oklahoma City, OK USA
                Author information
                http://orcid.org/0000-0002-6612-5653
                http://orcid.org/0000-0002-0036-9620
                Article
                53297
                10.1038/s41598-019-53297-w
                6858311
                31729418
                14b5e2da-bd26-4cc6-8c37-6a04412985ae
                © The Author(s) 2019

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 15 August 2019
                : 25 October 2019
                Funding
                Funded by: FundRef https://doi.org/10.13039/100000053, U.S. Department of Health & Human Services | NIH | National Eye Institute (NEI);
                Award ID: EY021725 P30
                Award Recipient :
                Funded by: FundRef https://doi.org/10.13039/100001818, Research to Prevent Blindness (RPB);
                Award ID: Unrestricted
                Award Recipient :
                Categories
                Article
                Custom metadata
                © The Author(s) 2019

                Uncategorized
                neuroimmunology,translational research
                Uncategorized
                neuroimmunology, translational research

                Comments

                Comment on this article